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RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES
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Key Messages
1. During influenza infections, 
most viral shedding occurs 
within a few days of illness 
onset.
2. Children may be more 
infectious than adults because 
they shed more virus.
3. The degree of viral shedding 
(infectiousness) correlates 
with symptoms and tympanic 
temperature.
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Introduction
Influenza is associated with significant morbidity and mortality through 
seasonal epidemics and occasional pandemics.1 An accurate understanding of 
the effectiveness of intervention strategies through experimental studies and 
mathematical models often involves profiling of infectiousness.2 
 Data on viral shedding from the respiratory tract, corresponding time lines, 
and duration of clinical illness are available from volunteer challenge studies.3 
Nonetheless, whether these results can be generalised to natural infections is 
uncertain, because participants are usually young adults with low levels of pre-
existing antibody to the influenza strain. Although there are studies on viral 
shedding in hospitalised patients,4,5 studies on the patterns of viral shedding 
after naturally acquired infection in out-patients or the community are limited. 
We analysed the dynamics of clinical illness and viral shedding in subjects 
that acquired influenza virus infections in a community setting, and inferred 
infectiousness profiles. 
Methods
This study was conducted from September 2008 to August 2009. In 2008, we 
conducted a cluster-randomised controlled trial to study the efficacy of hand 
hygiene and face masks to prevent the transmission of influenza in households.6 
Subjects presented to out-patient clinics and private hospital emergency rooms 
with at least two symptoms (fever ≥37.8ºC, cough, sore throat, headache, runny 
nose, phlegm, muscle pain) were recruited. They also had to be (1) a Hong Kong 
resident, (2) with symptoms started in the preceding 48 hours, and (3) with two or 
more household members free of influenza-like illness in the preceding 2 weeks. 
If this index patient was found to be positive for influenza A or B virus infection 
following a rapid antigen test, every household member was followed up with a 
series of three home visits (each of which involved responses to a questionnaire) 
and nasal and throat swabs (NTS). Symptoms were self-recorded daily, and the 
body temperature was recorded using a digital tympanic thermometer. 
 A total of 3868 NTS specimens were collected over the course of the study. 
Specimens were tested by quantitative reverse transcription polymerase chain 
reaction (RT-PCR) to detect molecular viral loads and determine influenza A or B 
virus infection.7 A subset of specimens were further tested to detect tissue culture 
infectious doses (TCID
50
) and determine replicating viral loads by quantitative 
viral dilutions.7
 There were three groups of symptoms: systemic symptoms (fever ≥37.8ºC, 
headache, myalgia), lower respiratory symptoms (cough, phlegm), and upper 
respiratory symptoms (sore throat, runny nose). Daily scores were tabulated by 
presence versus absence of each symptom and divided by the total number of 
symptoms in each group.3 Trends in symptom scores and quantitative viral loads 
were plotted since the day of self-reported illness onset for index cases and since 
the day of onset of acute respiratory illness (ARI) for secondary cases.8 
 Viral shedding in secondary cases was considered representative of natural 
infections. We used a modelling approach to infer infectiousness from viral 
shedding. We used a Bayesian approach to fit lognormal, Weibull, and gamma-
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form parametric forms to the viral shedding trajectories and 
selected between models using the Bayesian information 
criterion.9 All statistical analyses were conducted using 
R version 2.7.1 (R Development Core Team, Vienna, 
Austria)10 and WinBUGS version 1.4.11
Results
A total of 1015 household members from 322 households 
were followed up. All index subjects and 135 (13%) 
household members were confirmed by RT-PCR to have 
influenza virus infection. Among index cases, molecular 
viral shedding was highest on the day of symptom onset 
and gradually declined to undetectable levels within 
approximately 10 days (data not shown). The mean duration 
of shedding was 6 days. The dynamics of molecular viral 
shedding for influenza A and B virus infections were similar. 
Viral shedding was significantly higher in children than in 
adults with influenza A virus infections (data not shown). 
 Among secondary cases, 59 household members for 
whom the first NTS specimens collected were RT-PCR 
positive for influenza virus were excluded from analysis. 
An additional 17 household members were also excluded 
owing to the presence of ARI on the first home visit and 
RT-PCR confirmed influenza infection subsequently. Of the 
59 secondary cases analysed, 16 were influenza A/H1N1 
virus infections, 17 were influenza A/H3N2 infections, one 
was an influenza A/H1N1 and A/H3N2 coinfection, and 
the remaining 25 were influenza B virus infections. On the 
day of ARI onset, the most frequently reported symptoms 
were cough, nasal congestion/runny nose, and sore throat 
(Table). Thirty (51%) of them reported seeking medical 
care for their illness. 
 In secondary cases, peak molecular viral shedding for 
influenza A virus infections occurred on the day of ARI onset. 
Viral shedding declined steadily during the subsequent 7 
days (Fig 1). The viral shedding patterns for influenza A/
H1N1 and influenza A/H3N2 were similar (data not shown). 
Pre-ARI onset viral shedding was detected in four of the 15 
subjects (27%; 95% confidence interval [CI], 8-55%). Viral 
shedding of influenza B virus was more variable over time 
and a clear peak was not recorded; pre-ARI shedding was 
detected on days 1 and 2 before ARI onset in four of the 14 
subjects (29%; 95% CI, 8-58%). Influenza B viral shedding 
continued for about 6 days before declining to undetectable 
levels. 
 For influenza A virus infections, the peak replicating 
viral load (assessed by viral culture) was on the day of ARI 
onset and declined steadily over the subsequent 5 days (Fig 
1). For influenza B virus infections, TCID
50
 levels initially 
peaked on the day of ARI onset and were more variable 
over time. Pre-ARI onset replicating viral load was detected 
in one adult with influenza A infection, and two adults and 
three children with influenza B virus infection. For both 
influenza A and B virus infections, the average symptom 
score and mean tympanic temperature peaked on the day 
of ARI onset, and steadily declined to nil after 3 to 5 days 
(Fig 1). Systemic symptoms resolved at a faster rate than 
respiratory symptoms (Fig 1). 
 Asymptomatic viral shedding was detected by RT-PCR 
in eight of the 59 secondary cases (14%; 95% CI, 6-25%); 
five and three cases were positive for influenza A and B 
viruses, respectively. In two of these eight, only the NTS 
specimen collected on the final home visit was positive. 
These may be cases of pre-ARI onset shedding, as subjects 
could develop symptoms after our follow ups. Viral 
shedding was detected in a further seven of 59 subjects that 
were subclinical, or reported just one symptom over the 
course of illness. 
Infectiousness profiles
A modified lognormal form provided a good fit to influenza 
A virus infection molecular viral shedding patterns. 
Assuming infectiousness as proportional to molecular 
viral shedding determined by RT-PCR, infectiousness 
was maximal within 2 to 3 days of the ARI onset. If 
infectiousness was assumed to be proportional to log
10
 
molecular viral shedding or presence of detectable 
viral RNA, a longer duration could be inferred (Fig 2). 
Parametric forms did not offer any good fits to the influenza 
B molecular viral shedding patterns, or to replicating viral 
loads of influenza A or B assessed by viral culture. 
Discussion
Three different models have been used to describe 
infectiousness in influenza A virus infections over time. 
Assuming infectiousness is proportional to molecular viral 
shedding, most of the infectiousness is within 1 to 2 days 
(or 3 to 4 days) of the day of ARI onset (Fig 2). Considering 
the more rapid decline in replicating viral load compared 
to molecular viral shedding (Fig 1), the true duration of 
infectiousness may be overestimated by this method. 
 The mean serial interval for influenza infections is 
estimated to be 3.6 days,8 whereas the incubation period 
is 1.5 to 2 days.12 These estimates imply that the average 
time between ARI onset and transmission to a household 
contact is about 2 days, which is in line with the trend of 
Table. Symptoms of naturally acquired influenza A and B virus 
infections reported at the onset of acute respiratory illness
Symptom No. (%) of patients
Influenza A 
(n=26)
Influenza B 
(n=18)
Runny nose or nasal congestion 19 (73) 11 (61)
Cough 18 (69) 14 (78)
Sore throat 14 (54) 7 (39)
Headache 14 (54) 5 (28)
Phlegm 12 (46) 5 (28)
Myalgia 9 (35) 6 (33)
Fever ≥37.8ºC 8 (31) 8 (44)
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Fig 1. Patterns of viral shedding and symptom scores in naturally acquired influenza A (n=26) and B (n=18) virus infections
(a) The geometric mean viral shedding (the lower limit of detection of the RT-PCR assay is approximately 900 copies/mL), (b) the 
geometric mean tissue culture infectious dose (TCID50), (c) symptom scores, and (d) the mean tympanic temperature
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infectiousness over time based on molecular viral shedding 
and log
10
 viral shedding. 
 The trends in viral shedding and average symptom 
scores in secondary cases were consistent with findings in 
the volunteer study.3 Viral shedding for influenza A virus 
infections peaked at approximately the same time as ARI 
onset before subsiding. In a small proportion of cases, 
viral shedding was detected prior to ARI onset. The daily 
replicating viral load (assessed by TCID
50
) subsided at a 
faster rate than viral shedding (measured by RT-PCR). For 
influenza B infections, the patterns of viral shedding over 
the course of illness was more variable but consistent with 
data from the volunteer study, showing sustained shedding 
from the time of ARI onset for approximately 5 days.3 
 In secondary cases, systemic symptoms decline more 
quickly than respiratory symptoms for both influenza A 
and B virus infections.3 The more rapid decline of systemic 
symptoms (specifically fever, its profile is similar to viral 
shedding) can be attributed to the controlled decrease in 
immune response, as the virus is gradually cleared from the 
body.13 
 Among the 59 household contacts with RT-PCR–
confirmed infection, eight (14%; 95% CI, 6-25%) did not 
report any symptoms, and 15 (25%; 95% CI, 15-38%) were 
either asymptomatic or subclinical. Previous experimental 
infectiousness studies found a frequency of asymptomatic 
infection higher than the upper bound of our results3 and 
similarly in longitudinal studies that examined paired pre- 
and post-season serology in household contacts.14 Our 
study might have failed to detect infected subjects that were 
either shedding lower quantities of virus or shedding virus 
for a very short duration, and proportionally more of these 
subjects may be asymptomatic or subclinical.3,15 It is unclear 
whether asymptomatic individuals have the potential to 
transmit influenza virus.16 However, mathematical models 
typically assume that 33% to 50% of all infections are 
asymptomatic or subclinical, and the transmission potential 
of these subjects is half of that of symptomatic individuals.2,17 
Our results suggest that asymptomatic infections may be 
less important epidemiologically than previously thought. 
 The small sample size limited the ability to analyse 
the association between viral shedding and age or other 
characteristics, to characterise the patterns of viral shedding 
in secondary cases, and to ascertain an accurate proportion 
of asymptomatic and subclinical cases. In addition, our 
recruitment criteria and study design restricted recruitment 
to households without any illness during recruitment of the 
index subjects, possibly biasing the recruited households 
to those with a lower risk of infection or illness.6 Besides, 
this study was not designed to address the degree to which 
asymptomatic or subclinical cases are responsible for 
transmission in the community. Addition of serological 
evidence to our findings would have been valuable, and 
further studies should consider the inclusion of such testing.
Conclusions
Viral shedding determined by RT-PCR and TCID
50
 in 
natural community influenza virus infections peaks around 
the day of symptom onset. The trend of viral shedding 
closely matches the trends of the average symptom 
score and mean tympanic temperature suggesting that 
infectiousness is likely to be correlated with illness severity, 
and that asymptomatic persons may be less important 
in influenza transmission than previously thought. The 
greatest infectiousness of influenza A virus is within 1 
to 2 days following ARI onset. Individuals should take 
protective measures against transmission while they have 
febrile illness, and if possible while any symptoms persist. 
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